Insiders AbbVie Inc.

Equities

ABBV

US00287Y1091

Market Closed - Nyse Other stock markets 04:00:02 2024-06-07 pm EDT			5-day change	1st Jan Change
169.4 ^USD	+0.50%		+5.07%	+9.32%

12:18am	Top law firms in US opioid lawsuits to get hundreds of millions in fees	RE
Jun. 07	AbbVie's tight grip on Humira market raises concerns about biosimilars	RE

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Abbvie Inc. Announces Board Changes, Effective July 1, 2024	Apr. 26	CI
Abbvie Insider Sold Shares Worth $3,716,757, According to a Recent SEC Filing	Mar. 22	MT
Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing	Mar. 21	MT
Repeat & Correct : Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale -- Update	Mar. 19	DJ
Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale -- Update	Mar. 19	DJ
Abbvie Insider Sold Shares Worth $1,754,555, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $12,153,957, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $908,688, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $2,509,002, According to a Recent SEC Filing	Mar. 01	MT
Abbvie Insider Sold Shares Worth $9,184,048, According to a Recent SEC Filing	Feb. 23	MT
AbbVie CEO to Retire; COO Robert Michael Named Successor	Feb. 20	MT
AbbVie Names Robert Michael CEO, Richard Gonzalez Executive Chair	Feb. 20	MT
AbbVie: new CEO on July 1	Feb. 20	CF
AbbVie Names Robert Michael to Succeed Richard Gonzalez as CEO	Feb. 20	DJ
AbbVie Names President Robert Michael as CEO	Feb. 20	MT
Abbvie, Inc. Appoints Robert A. Michael as Member of the Board of Directors and Richard A. Gonzalez as Executive Chairman of the Board of Directors	Feb. 20	CI
AbbVie Inc. Announces Chief Executive Officer Changes	Feb. 20	CI
Abionyx: former AbbVie executive appointed CMO	Jan. 09	CF
AbbVie Insider Sold Shares Worth $450,545, According to a Recent SEC Filing	Dec. 29	MT
Cerevel options trading surge before AbbVie deal news raises eyebrows	Dec. 06	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders AbbVie Inc.

Equities

ABBV

US00287Y1091

Insiders

Filters